Immunomodulatory Therapy for Oncology Clinicians
Source: Immunotherapy for Practicing Clinicians

Module

In this interactive CME-certified activity, Charles G. Drake, MD, PhD, provides an overview of the use of immunomodulatory agents in the treatment of patients with cancer.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Utilize immunotherapies appropriately for the treatment of selected patients with cancer
  • Manage the adverse effects associated with immunotherapies used to treat cancer
  • Discuss clinical trials evaluating novel immunomodulatory agents with appropriate patients

Topics covered include:

  • Introduction to Immunomodulatory Approaches for Cancer Treatment
  • Vaccine Immunotherapy for Prostate Cancer
  • Blocking the Immune Checkpoint Molecule CTLA-4
  • Programmed Death 1: An Immune Checkpoint Molecule Important in Renal Cell Carcinoma, Melanoma, and NSCLC
  • Combining Immune Checkpoint Blockade With Conventional Chemotherapy in Lung Cancer
  • Combined Immune Checkpoint Blockade: The Future of Immunotherapy?
 

Faculty

  • Charles G. Drake
    MD, PhD

Credit Information

  • Release Date:
    July 10, 2012
  • Expiration Date:
    July 09, 2013
  • Physicians:
    maximum of 0.75 AMA PRA Category 1 Credits